Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Merck
McKesson
US Department of Justice
Baxter
Farmers Insurance
Healthtrust
US Army
Mallinckrodt

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,338,317

« Back to Dashboard

Summary for Patent: 4,338,317
Title: Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
Abstract:Phenoxyethyl substituted-1,2,4,-triazolones having antidepressant properties typified by 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyethyl)- 2H-1,2,4-triazol-3(4H)-one are disclosed.
Inventor(s): Temple, Jr.; Davis L. (Evansville, IN), Lobeck, Jr.; Walter G. (Evansville, IN)
Assignee: Mead Johnson & Company (Evansville, IN)
Application Number:06/244,464
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 4,338,317

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 4,338,317

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 384022 ➤ Try a Free Trial
Austria 388555 ➤ Try a Free Trial
Austria A104582 ➤ Try a Free Trial
Austria A209884 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
McKinsey
Moodys
Harvard Business School
Cantor Fitzgerald
AstraZeneca
Accenture
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.